X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Abstract : ABSTRACT: X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder. The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal membrane protein ALDP which is involved in the transmembrane transport of very long-chain fatty acids (VLCFA; >C22). A defect in ALDP results in elevated levels of VLCFA in plasma and tissues. The clinical spectrum in males with X-ALD ranges from isolated adrenocortical insufficiency and slowly progressive myelopathy to devastating cerebral demyelination. The majority of heterozygous females will develop symptoms by the age of 60 years. In individual patients the disease course remains unpredictable. This review focuses on the diagnosis and management of patients with X-ALD and provides a guideline for clinicians that encounter patients with this highly complex disorder.
Type de document :
Article dans des revues
Orphanet Journal of Rare Diseases, BioMed Central, 2012, 7 (1), pp.51. <10.1186/1750-1172-7-51>


http://www.hal.inserm.fr/inserm-00755770
Contributeur : Ed. BMC <>
Soumis le : mercredi 21 novembre 2012 - 21:00:10
Dernière modification le : jeudi 22 novembre 2012 - 09:00:48

Fichiers

1750-1172-7-51.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Marc Engelen, Stephan Kemp, Marianne De Visser, Björn Van Geel, Ronald Wanders, et al.. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.. Orphanet Journal of Rare Diseases, BioMed Central, 2012, 7 (1), pp.51. <10.1186/1750-1172-7-51>. <inserm-00755770>

Exporter

Partager

Métriques

Consultation de la notice

70